Analgesics

A mainstay diabetes drug reduced pain and stiffness and improved function in overweight people with knee osteoarthritis, a new study has found. It may mean that, as a result, invasive knee replacement surgery can be delayed for as long as possible.

The US Food and Drug Administration has approved the use of a novel painkiller for short-term moderate-to-severe pain in adults. It’s the first of a new class of analgesics to be approved in over 20 years - and, importantly, isn't addictive.

Taking one of the most widely-used painkillers for a prolonged period increases the risk of serious complications in older folks, according to a new study. It may mean rethinking the drug’s use as a first-line treatment for chronic conditions.